SELLAS Life Sciences Group, Inc. (FRA:RXK3)
1.294
+0.090 (7.48%)
At close: Dec 4, 2025
12.52% (1Y)
| Market Cap | 212.53M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -22.11M |
| Shares Out | n/a |
| EPS (ttm) | -0.24 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 1,386 |
| Open | 1.294 |
| Previous Close | 1.204 |
| Day's Range | 1.294 - 1.294 |
| 52-Week Range | 0.801 - 2.600 |
| Beta | n/a |
| RSI | 45.87 |
| Earnings Date | Mar 18, 2026 |